Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes (Q33382437)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes |
scientific article |
Statements
1 reference
Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes (English)
1 reference
Norikazu Masuda
1 reference
Takanori Ishida
1 reference
Takayoshi Kiba
1 reference
Motohiro Takeda
1 reference
Kotone Matsuyama
1 reference
Ryota Ishiwata
1 reference
Yuichi Takatsuka
1 reference
Shinzaburo Noguchi
1 reference
Chikashi Ishioka
1 reference
Masanori Fukushima
1 reference
Noriaki Ohuchi
1 reference
12 December 2008
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference